Pricing

Log inSign up

Facile Therapeutics

11 people · 0 jobs
‌

Facile Therapeutics is bringing Ebselen into the clinic to demonstrate it will be effective in preventing the recurrence of CDI in a Proof-of-Concept (PoC) clinical trial.

Industries

Biotechnology

Headquarters

Belmont, United States

Employees

1-10

Links

Org chart

Marc Navre
Co-Founder, CEO & CSO
Collapse
Allan Wagman
VP of CMC, Consulting Position

Board & advisors

Matthew Bogyo
Co-Founder, Head of Scientific Advisory Board
Ciaran P. Kelly
Chair, Clinical Advisory Board
Peter Tam
Director
Sahil Khanna
Advisor
Ian Friedland
Strategic Medical Advisor
Christine Murray
Strategic Regulatory Advisor
Dan Lundberg
Commercial Advisor
Andrew Parratt
Commercial Strategy Advisor
Andrew McCandlish
Non-Dilutive Funding Advisor

Teams

+4

Advisory Roles

8 people · 0 jobs

Leadership Team

3 people · 0 jobs

Offices

Similar companies

Gilead Sciences

159 followers

Regeneron

130 followers

Illumina

79 followers

Agilent Technologies

81 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

28 followers

Cytiva

16 followers

PerkinElmer

12 followers

Editas Medicine

5 followers

Organogenesis

5 followers

Explore companies